Methods The present studies based on 40 patients, which conducted a questionnaire and
laboratory examination. The age of tested persons ranged from 18–74years. The group of …

OBJECTIVE: To develop a disease outcome instrument measuring localized scleroderma
(LS) severity and to determine its reliability. METHODS: Patients with LS were evaluated by …

Morphea (localized scleroderma) is an inflammatory connective tissue disease. Borrelia
burgdorferi, as a causative factor, has been discussed controversially. The aim of this …

Background Possible associations of localized scleroderma (LS) with Lyme borreliosis (LB)
were reported in certain countries, though denied in others. Therefore, it is still under …

Despite considerable achievements in the study of localized scleroderma, the etiology of the
disease has not been investigated completely. Borrelia burgdorferi—the agent of Lyme …

Objectives The role of B. burgdorferi in the etiology of sclerodermia circumscripta (SC) and
lichen sclerosus et atrophicus (LSA) are is reported in numerous, however controversial …

No decision has been made yet as to whether or not the origin of the circumscribed
scleroderma (morphea) is spirochetal. We describe a morphea-like skin lesion that …

The occurrence of morphea has been attributed to Borrelia, burgdorferi infection, but the
relationship between localised scleroderma and borreliosis remains controverted …

Localized scleroderma is a rare autoimmune disorder affecting the dermis, subcutaneous
tissue and deeper structures. The course of localized scleroderma includes three stages …

Eight genotypes of Borrelia burgdorferi are known currently. In Slovakia (Carpathian
Euroregion) the most frequent genotypes are B. garini, B. afzelii, as well as B. valaisiana and …